Breaking News, Collaborations & Alliances

AGC Biologics Partners with Evax

Advances antigen VLP conjugate product.

Author Image

By: Charlie Sternberg

Associate Editor

AGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new partnership with Evax, a developer of equine vaccines to treat chronic diseases, respiratory disorders and allergies.   Through this partnership, Evax advances its Antigen VLP Conjugate product into the clinical stage, and AGC Biologics will supply cGMP support for the pivotal studies.    AGC Biologics is providing services at its Heidelberg facility using microbial-based...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters